FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W110975038> ?p ?o ?g. }

• W110975038 endingPage "463" @default.
• W110975038 startingPage "459" @default.
• W110975038 abstract "Different etiopathological mechanisms of enuresis are today under study, and different therapies and drugs have been proposed. The Italian Multicentric Trial was undertaken in twelve pediatric and urological centers in order to assess the efficacy of two of the most popular drugs, desmopressin (DDAVP) and oxybutynin.114 enuretic patients were enrolled in the study. After a 2-week observation period, 66 patients with primary monosymptomatic enuresis were treated with DDAVP, 30 micrograms/day intranasally, for 6 weeks, 48 patients with enuresis and voiding dysfunction were randomly assigned to a protocol with oxybutynin alone or oxybutynin plus DDAVP. The efficacy of the two drugs was measured in terms of reduction of wet nights per week during the 6-week treatment period and a 2-week follow-up period. Children with 0-3 dry nights/week were considered as nonresponders.Patients with monosymptomatic enuresis treated with DDAVP reported a significantly lower number of wet night during treatment than during the baseline period, with 79% showing a 'good' (6-7 dry nights/week) or 'intermediate' response (4-5 dry nights/week). Of the patients with diurnal voiding disturbances and enuresis, those treated with oxybutynin alone had a 54% success rate. The patients treated with both oxybutynin and DDAVP showed a better response, with a 71% rate of success.The efficacy of the two drugs is confirmed in patients carefully selected on the clinical basis of voiding disturbances. In patients with enuresis and voiding dysfunction, the reduced urinary output and the lower bladder filling rate due to DDAVP can reduce uninhibited bladder contractions, thus enhancing the oxybutynin action." @default.
• W110975038 created "2016-06-24" @default.
• W110975038 creator A5000353693 @default.
• W110975038 creator A5002829562 @default.
• W110975038 creator A5004388630 @default.
• W110975038 creator A5011328299 @default.
• W110975038 creator A5014320139 @default.
• W110975038 creator A5019893144 @default.
• W110975038 creator A5020474237 @default.
• W110975038 creator A5023828480 @default.
• W110975038 creator A5026343724 @default.
• W110975038 creator A5040193380 @default.
• W110975038 creator A5045390689 @default.
• W110975038 creator A5045474168 @default.
• W110975038 creator A5055964273 @default.
• W110975038 creator A5058771101 @default.
• W110975038 creator A5063392318 @default.
• W110975038 creator A5065575432 @default.
• W110975038 creator A5074672508 @default.
• W110975038 creator A5075772732 @default.
• W110975038 creator A5078342743 @default.
• W110975038 creator A5078516182 @default.
• W110975038 creator A5078753441 @default.
• W110975038 creator A5080509284 @default.
• W110975038 creator A5083346713 @default.
• W110975038 creator A5086610820 @default.
• W110975038 creator A5088577123 @default.
• W110975038 date "1997-01-01" @default.
• W110975038 modified "2023-10-16" @default.
• W110975038 title "Nocturnal Enuresis and Daytime Wetting: A Multicentric Trial with Oxybutynin and Desmopressin" @default.
• W110975038 doi "https://doi.org/10.1159/000474507" @default.
• W110975038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9187908" @default.
• W110975038 hasPublicationYear "1997" @default.
• W110975038 type Work @default.
• W110975038 sameAs 110975038 @default.
• W110975038 citedByCount "57" @default.
• W110975038 countsByYear W1109750382013 @default.
• W110975038 countsByYear W1109750382014 @default.
• W110975038 countsByYear W1109750382016 @default.
• W110975038 countsByYear W1109750382017 @default.
• W110975038 countsByYear W1109750382019 @default.
• W110975038 countsByYear W1109750382023 @default.
• W110975038 crossrefType "journal-article" @default.
• W110975038 hasAuthorship W110975038A5000353693 @default.
• W110975038 hasAuthorship W110975038A5002829562 @default.
• W110975038 hasAuthorship W110975038A5004388630 @default.
• W110975038 hasAuthorship W110975038A5011328299 @default.
• W110975038 hasAuthorship W110975038A5014320139 @default.
• W110975038 hasAuthorship W110975038A5019893144 @default.
• W110975038 hasAuthorship W110975038A5020474237 @default.
• W110975038 hasAuthorship W110975038A5023828480 @default.
• W110975038 hasAuthorship W110975038A5026343724 @default.
• W110975038 hasAuthorship W110975038A5040193380 @default.
• W110975038 hasAuthorship W110975038A5045390689 @default.
• W110975038 hasAuthorship W110975038A5045474168 @default.
• W110975038 hasAuthorship W110975038A5055964273 @default.
• W110975038 hasAuthorship W110975038A5058771101 @default.
• W110975038 hasAuthorship W110975038A5063392318 @default.
• W110975038 hasAuthorship W110975038A5065575432 @default.
• W110975038 hasAuthorship W110975038A5074672508 @default.
• W110975038 hasAuthorship W110975038A5075772732 @default.
• W110975038 hasAuthorship W110975038A5078342743 @default.
• W110975038 hasAuthorship W110975038A5078516182 @default.
• W110975038 hasAuthorship W110975038A5078753441 @default.
• W110975038 hasAuthorship W110975038A5080509284 @default.
• W110975038 hasAuthorship W110975038A5083346713 @default.
• W110975038 hasAuthorship W110975038A5086610820 @default.
• W110975038 hasAuthorship W110975038A5088577123 @default.
• W110975038 hasConcept C126322002 @default.
• W110975038 hasConcept C126894567 @default.
• W110975038 hasConcept C142724271 @default.
• W110975038 hasConcept C204787440 @default.
• W110975038 hasConcept C2777844464 @default.
• W110975038 hasConcept C2778531004 @default.
• W110975038 hasConcept C2778702241 @default.
• W110975038 hasConcept C2778941218 @default.
• W110975038 hasConcept C2780610425 @default.
• W110975038 hasConcept C2781020410 @default.
• W110975038 hasConcept C42219234 @default.
• W110975038 hasConcept C71924100 @default.
• W110975038 hasConcept C77411442 @default.
• W110975038 hasConceptScore W110975038C126322002 @default.
• W110975038 hasConceptScore W110975038C126894567 @default.
• W110975038 hasConceptScore W110975038C142724271 @default.
• W110975038 hasConceptScore W110975038C204787440 @default.
• W110975038 hasConceptScore W110975038C2777844464 @default.
• W110975038 hasConceptScore W110975038C2778531004 @default.
• W110975038 hasConceptScore W110975038C2778702241 @default.
• W110975038 hasConceptScore W110975038C2778941218 @default.
• W110975038 hasConceptScore W110975038C2780610425 @default.
• W110975038 hasConceptScore W110975038C2781020410 @default.
• W110975038 hasConceptScore W110975038C42219234 @default.
• W110975038 hasConceptScore W110975038C71924100 @default.
• W110975038 hasConceptScore W110975038C77411442 @default.
• W110975038 hasIssue "4" @default.
• W110975038 hasLocation W1109750381 @default.
• W110975038 hasLocation W1109750382 @default.
• W110975038 hasOpenAccess W110975038 @default.

• next